Cargando…
A Rev-Independent gag/pol Eliminates Detectable psi-gag Recombination in Lentiviral Vectors
Lentiviral vectors (LVs) are being developed for clinical use in humans for applications including gene therapy and immunotherapy. A safety concern for use of LVs in humans is the generation of replication-competent lentivirus (RCL), which may arise due to recombination between the split genomes of...
Autores principales: | Tareen, Semih U., Nicolai, Christopher J., Campbell, David J., Flynn, Patrick A., Slough, Megan M., Vin, Chintan D., Kelley-Clarke, Brenna, Odegard, Jared M., Robbins, Scott H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869434/ https://www.ncbi.nlm.nih.gov/pubmed/24380052 http://dx.doi.org/10.1089/biores.2013.0037 |
Ejemplares similares
-
Virological and Preclinical Characterization of a Dendritic Cell Targeting, Integration-deficient Lentiviral Vector for Cancer Immunotherapy
por: Odegard, Jared M., et al.
Publicado: (2015) -
FRET analysis of HIV‐1 Gag and GagPol interactions
por: Takagi, Shimon, et al.
Publicado: (2017) -
Modulation of HIV-1 Gag/Gag-Pol frameshifting by tRNA abundance
por: Korniy, Natalia, et al.
Publicado: (2019) -
Effects of reduced gag cleavage efficiency on HIV-1 Gag-Pol package
por: Lin, Yi-Ru, et al.
Publicado: (2022) -
Design of a titering assay for lentiviral vectors utilizing direct extraction of DNA from transduced cells in microtiter plates
por: Murphy, Michele E, et al.
Publicado: (2016)